Drug intelligence / Profile preview

Xian Qi Verning Granule

Development stage: Unknown
Lead developer: Shanxi Buchang Pharmaceutical
Administration: Oral

Overview

Xian Qi Verning Granule is a Traditional Chinese Medicine (TCM) product developed by Shanxi Buchang Pharmaceutical. It is formulated as a granule for oral administration and is approved in China for general health maintenance, specifically targeting conditions characterized by Qi and Yin deficiency. The preparation is traditionally used to invigorate Qi, nourish Yin, warm the kidneys, and calm the nerves (Shen), making it suitable for patients experiencing fatigue, insomnia, palpitations, and general physical weakness. As a botanical extract combination, it leverages the synergistic effects of multiple herbal ingredients common in Chinese pharmacopeia.

Brand names: Xian Qi Verning Granule
Other names: Xianqi Wenning GranuleXian Qi Wen Ning Ke Li仙芪温宁颗粒

Beyond the preview

Go deeper on Xian Qi Verning Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xian Qi Verning Granule.

Explore the full profile